Who Might Not Be a Good Fit for Psychedelic Therapy?

Psychedelic therapy holds real promise — but it isn’t the right choice for everyone. And that’s okay. Knowing who it suits (and who it doesn’t) isn’t a weakness of the field. It’s actually a sign of its maturity and care.

If you’re wondering whether this kind of therapy might be right for you, here’s an honest, clear-eyed look at the key safety considerations — and the questions worth bringing into the conversation.

When It’s Not the Right Approach

Some situations genuinely make psychedelic therapy inadvisable — no matter how much someone might want to pursue it:

• A personal or family history of psychosis or schizophrenia-spectrum disorders: Psychedelics can trigger or worsen psychotic episodes in people who are predisposed. This is something every evidence-based protocol takes very seriously.
• A personal or family history of Bipolar I disorder: There’s a real risk of setting off a manic episode, which is why most clinical programs consider this a firm contraindication.
• Being in the middle of a psychiatric crisis: Psychedelic therapy isn’t a tool for emergencies. It needs a foundation of stability to be safe. If someone is in acute crisis, that needs attention first.
• Certain heart conditions: Some psychedelics temporarily raise heart rate and blood pressure, so any cardiovascular concerns are carefully evaluated during the screening process.

When It’s a “Maybe, With Care”

These situations don’t automatically close the door — but they do call for thoughtful, individualized evaluation with a qualified practitioner:

• Active suicidal thoughts or intent: While psychedelic therapy is being studied for depression-related distress, acute suicidal intent calls for more immediate support. Readiness and stability are prerequisites, not shortcuts.
• Certain medications: Some medications interact with psychedelic compounds in ways that affect safety or how well the therapy works. A thorough medication review is essential — for people in Kitchener-Waterloo, Sarnia, and across Canada, being fully open with your practitioner about everything you take is key.
• Pregnancy and breastfeeding: The safety profile for these stages hasn’t been established yet, so clinical programs don’t currently include pregnant or breastfeeding individuals.
• Certain neurological conditions: Things like epilepsy, specific brain injuries, and some other neurological issues may require additional evaluation before moving forward.

Screening Is About Care, Not a Test

The screening process isn’t something you have to “pass.” It’s a genuine act of care. A skilled practitioner wants to make sure that if you do move forward, you’re as safe and supported as possible — and set up for the best possible experience.

Sometimes the Answer Is “Not Right Now”

It’s also worth remembering: being contraindicated today doesn’t always mean forever. Some factors shift over time — with medication adjustments, preparatory therapy work, or other changes in your situation. A thoughtful practitioner can help you map out a path that makes sense for you.

Not sure if psychedelic therapy is right for you? A free conversation is the best place to start — book a free Info Call with ATMA CENA.